Stock listing
OTC:SSKN STRATA Skin Sciences, Inc. Stock
Follow STRATA Skin Sciences, Inc. into a list and get an email when it puts out news.
Share price · OTC:SSKN
$0.0001 USD 0.0000 (0.0%)
Close on Nov 5, 2026
- Day range
- $0.0001 – $0.0001 USDNov 5, 2026
- Market cap
- $589 USDAt the close on Nov 5, 2026 · price × 5.89M shares outstanding
- Traded on an average day
- $6 USDMedian day 0 shares · 32 days with no trades · last 3 months, Aug 5, 2026 – Nov 5, 2026

Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · OTC:SSKN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | -0.0001 | -50.0% | $0.0001 | $0.0001 | $0.0001 | 2,700 | |
| $0.0002 | +0.0001 | +100.0% | $0.0002 | $0.0002 | $0.0002 | 10,309 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | -0.0001 | -50.0% | $0.0001 | $0.0001 | $0.0001 | 560 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 143,165 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 1,001 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 800 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | -0.0048 | -96.0% | $0.0002 | $0.0002 | $0.0002 | 182 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 1,009 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 619 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 2,500 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 981 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 157 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 653 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 1,010 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 420 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 11,606 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 1,057 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 8,345 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 20,055 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 1,822 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 5,720 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0050 | 0 | |
| $0.0050 | -0.0005 | -9.1% | $0.0002 | $0.0050 | $0.0002 | 2,333 | |
| $0.0055 | 0.0000 | 0.0% | $0.0055 | $0.0055 | $0.0055 | 0 | |
| $0.0055 | 0.0000 | 0.0% | $0.0055 | $0.0055 | $0.0055 | 0 | |
| $0.0055 | 0.0000 | 0.0% | $0.0055 | $0.0055 | $0.0055 | 0 |
Splits
3 splits since 2014 · OTC:SSKN · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation | |
| 1-for-5 | Consolidation | |
| 1-for-10 | Consolidation |
- Ticker
- OTC:SSKN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest deck · Dec 17, 2025
Investor Presentation (December 2025)
Investor deck · 44 slides
STRATA Skin Sciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- Calls
- 16 calls with a replay · 16 with a transcript · latest Nov 13, 2025
- Decks
- 25 decks · latest Dec 17, 2025
Valuation
EV/sales 0.3× against a median of 2.5×: 2nd lowest of 6 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · price Nov 5, 2026
- Enterprise value
- $8.36M USD
- P/E
- Loss
- EV/sales
- 0.3×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.0×
- Gross margin
- 58.3%
- Operating margin
- −19.0%
- Net margin
- −20.4%
- Debt to equity
- 5.6×
- Beta vs S&P 500
- -0.94
Medical devices & supplies: the 10 companies nearest in size, of 449 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| STRATA Skin Sciences, Inc. · OTC:SSKN | US$589 | US$8.36M | n/a | 0.3× | n/a | 0.0× | −20.4% | 5.6× | -0.94 |
| Zero Candida Technologies Inc. · TSXV:ZCT | US$1.43M | −US$59,297 | n/a | n/a | n/a | 2.2× | n/a | 0.0× | -0.17 |
| Osteopore Ltd. · ASX:OSX | US$1.38M | US$596,079 | n/a | 0.3× | n/a | n/a | −121.8% | n/a | n/a |
| SpectraCure AB · OMXSTO:SPEC | US$978,306 | US$1.10M | n/a | 32.1× | n/a | 0.1× | n/a | 0.1× | n/a |
| Odyssey Health Inc. · OTC:ODYY | US$716,421 | US$594,060 | n/a | n/a | n/a | n/a | n/a | n/a | 0.58 |
| S2Medical AB Class B · OMXSTO:S2M | US$355,391 | US$300,229 | n/a | 0.2× | n/a | 0.4× | −62.1% | 0.0× | n/a |
| Imaging Dynamics Company, Ltd. · TSXV:IDL | US$252,238 | US$243,907 | n/a | 8.8× | n/a | n/a | n/a | n/a | -0.28 |
| Profusa, Inc. · NASDAQ:PFSA | US$195,866 | −US$8.20M | n/a | n/a | n/a | 0.0× | n/a | 0.0× | 1.99 |
| Sigyn Therapeutics, Inc. · OTC:SIGY | US$161,983 | US$3.93M | n/a | n/a | n/a | n/a | n/a | n/a | 1.70 |
| Safe SA · EURONEXT:ALSAF | US$139,941 | US$14.53M | n/a | 2.5× | n/a | n/a | −75.9% | n/a | n/a |
| Vicarious Surgical, Inc. · OTC:RBOT | US$19,432 | −US$9.77M | n/a | n/a | n/a | 0.0× | n/a | 0.0× | 1.95 |
| Median of the others | US$303,815 | US$447,145 | 2.5× | 0.1× | −75.9% | 0.0× | 1.14 |
Forecasts
1 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 10.80 USD · Analysts' mean
- EPS, year to Dec 2025
- -1.80 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Dolev Rafaeli | Vice-Chairman of the Board, President and Chief Executive Officer |
| Erica Jordan | President and Chief Executive Officer |
| Christopher Lesovitz | Chief Financial Officer |
Board
| Director | Role |
|---|---|
| Uri Geiger | Chairman of the Board |
| Dolev Rafaeli | Vice-Chairman of the Board, President and Chief Executive Officer |
| Irit Yaniv | Director |
| Samuel Rubinstein | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| STRATA Skin Sciences (OTC:SSKN) Q3 2025 Earnings Call | Thu, Nov 13, 2025 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q2 2025 Earnings Call | Wed, Aug 13, 2025 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q1 2025 Earnings Call | Wed, May 14, 2025 · 5:00 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q4 2024 Earnings Call | Thu, Mar 27, 2025 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q3 2024 Earnings Call | Wed, Nov 13, 2024 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q2 2024 Earnings Call | Wed, Aug 14, 2024 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q1 2024 Earnings Call | Wed, May 15, 2024 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q4 2023 Earnings Call | Wed, Mar 27, 2024 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q3 2023 Earnings Call | Tue, Nov 14, 2023 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q2 2023 Earnings Call | Wed, Aug 09, 2023 · 4:30 PM ET | Replay |
All 16 calls
| Call | When | Status |
|---|---|---|
| STRATA Skin Sciences (OTC:SSKN) Q4 2022 Earnings Call | Fri, Mar 31, 2023 · 8:30 AM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q3 2022 Earnings Call | Wed, Nov 09, 2022 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q2 2022 Earnings Call | Wed, Aug 10, 2022 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q1 2022 Earnings Call | Wed, May 11, 2022 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q4 2021 Earnings Call | Mon, Mar 21, 2022 · 4:30 PM ET | Replay |
| STRATA Skin Sciences (OTC:SSKN) Q3 2021 Earnings Call | Wed, Nov 10, 2021 · 4:30 PM ET | Replay |
Results days
| Quarter | Results |
|---|---|
| Q3 2025 | Nov 13, 2025 · After close |
| Q2 2025 | Aug 13, 2025 · After close |
| Q1 2025 | May 14, 2025 · After close |
| Q4 2024 | Mar 25, 2025 · Before open |
| Q3 2024 | Nov 13, 2024 · After close |
| Q2 2024 | Aug 14, 2024 · After close |
| Q1 2024 | May 15, 2024 · After close |
| Q4 2023 | Mar 27, 2024 · After close |
| Q3 2023 | Nov 14, 2023 · After close |
| Q2 2023 | Aug 9, 2023 · After close |
All 20 quarters
| Quarter | Results |
|---|---|
| Q1 2023 | May 15, 2023 · After close |
| Q4 2022 | Mar 31, 2023 · Before open |
| Q3 2022 | Nov 9, 2022 · After close |
| Q2 2022 | Aug 10, 2022 · After close |
| Q1 2022 | May 11, 2022 · After close |
| Q4 2021 | Mar 21, 2022 · After close |
| Q3 2021 | Nov 10, 2021 · After close |
| Q2 2021 | Aug 16, 2021 · After close |
| Q1 2021 | May 12, 2021 · After close |
| Quarter to Dec 31, 2020 | Mar 24, 2021 · After close |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2025) | Investor deck | 44 slides | Dec 17, 2025 |
| Investor Presentation (August 2025) | Investor deck | 45 slides | Aug 18, 2025 |
| Investor Presentation (December 2024) | Investor deck | 37 slides | Dec 11, 2024 |
| Q3 2023 Earnings Presentation | Earnings | 12 slides | Nov 15, 2023 |
| Investor Presentation (January 2023) | Investor deck | 22 slides | Jan 9, 2023 |
| Investor Presentation (August 2022) | Investor deck | 28 slides | Aug 29, 2022 |
| Investor Presentation (May 2022) | Investor deck | 27 slides | May 19, 2022 |
| Investor Presentation (April 2022) | Investor deck | 28 slides | Apr 1, 2022 |
| Investor Presentation (March 2022) | Investor deck | 30 slides | Mar 14, 2022 |
| Investor Presentation (January 2022) | Investor deck | 30 slides | Jan 10, 2022 |
All 25 decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30.7M | 33.6M | 33.4M | 36.2M | 30.0M | 23.1M | 31.6M | 29.9M | 31.4M | 31.8M |
| Cost of revenue | 12.8M | 14.5M | 14.9M | 14.4M | 10.1M | 8.96M | 11.3M | 12.7M | 13.5M | 12.6M |
| Gross profit | 17.9M | 19.1M | 18.5M | 21.8M | 19.9M | 14.1M | 20.3M | 17.1M | 18.0M | 19.1M |
| Research and development | 421.0K | 883.0K | 1.32M | 1.03M | 1.43M | 1.27M | 1.00M | 1.06M | 1.71M | 1.93M |
| Selling, general and administrative | 10.2M | 11.3M | 10.5M | 10.1M | 9.71M | 7.90M | 10.3M | 8.79M | 7.40M | 7.64M |
| Operating income | -5.83M | -9.26M | -8.60M | -4.65M | -4.40M | -4.08M | -3.01M | -3.35M | -2.41M | -3.60M |
| Depreciation and amortization | 4.47M | 5.31M | 5.90M | 5.69M | 4.09M | 3.91M | 4.82M | 5.40M | 6.34M | 6.37M |
| EBITDA | -1.37M | -3.95M | -2.70M | 1.04M | -316.0K | -165.0K | 1.81M | 2.04M | 3.93M | 2.77M |
| Interest expense | 1.96M | 2.11M | 1.64M | 926.0K | 314.0K | 211.0K | 515.0K | 0 | 3.20M | 4.90M |
| Income before tax | -6.25M | -10.3M | -10.9M | -5.49M | -2.67M | -4.14M | -3.94M | -4.30M | -18.7M | -3.08M |
| Income tax | 12.0K | -170.0K | -92.0K | 63.0K | 34.0K | 275.0K | -149.0K | -264.0K | 129.0K | 255.0K |
| Net income | -6.26M | -10.1M | -10.8M | -5.55M | -2.71M | -4.41M | -3.79M | -4.03M | -21.5M | -3.33M |
| Earnings per share, basic | -0.13 | -0.26 | -0.31 | -0.16 | -0.08 | -0.13 | -0.12 | -0.13 | -3.26 | -1.44 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7.91M | 7.26M | 6.78M | 5.43M | 12.6M | 10.6M | 8.13M | 16.5M | 4.07M | 3.93M |
| Short-term investments | 0 | 0 | ||||||||
| Receivables | 4.12M | 5.25M | 4.44M | 4.47M | 3.43M | 2.94M | 4.39M | 3.39M | 3.14M | 3.39M |
| Inventory | 2.81M | 2.25M | 2.67M | 5.55M | 3.49M | 3.44M | 3.03M | 2.79M | 3.01M | 2.82M |
| Current assets | 15.6M | 16.6M | 15.5M | 17.5M | 20.0M | 24.8M | 23.6M | 23.2M | 10.8M | 10.8M |
| Property, plant and equipment | 7.52M | 6.52M | 5.37M | 5.30M | 7.70M | 10.2M | ||||
| Goodwill | 1.43M | 2.66M | 6.52M | 8.80M | 8.80M | 8.80M | 8.80M | 8.80M | 8.80M | 8.80M |
| Total assets | 30.5M | 36.2M | 42.0M | 52.3M | 46.6M | 46.8M | 47.3M | 47.5M | 38.6M | 43.2M |
| Accounts payable | 2.76M | 2.43M | 3.34M | 3.42M | 2.82M | 2.76M | 1.88M | 6.26M | 2.28M | 1.85M |
| Current liabilities | 26.7M | 14.6M | 12.2M | 13.4M | 12.8M | 18.8M | 17.4M | 8.62M | 7.67M | 6.13M |
| Long-term debt | 15.2M | 15.0M | 7.48M | 7.32M | 1.05M | 7.14M | 7.85M | 21.8M | ||
| Total debt | 16.3M | 16.4M | 15.6M | 8.44M | 8.03M | 10.9M | 8.67M | 7.40M | 10.6M | 23.8M |
| Total liabilities | 27.6M | 31.2M | 29.3M | 30.4M | 21.2M | 20.9M | 18.7M | 16.3M | 16.4M | 28.5M |
| Shareholders' equity | 2.91M | 4.97M | 12.7M | 21.8M | 25.4M | 25.9M | 28.7M | 31.2M | 22.2M | 14.7M |
| Shares outstanding | 46.5M | 38.1M | 34.9M | 34.7M | 34.1M | 33.6M | 32.0M | 29.9M | 6.60M | 2.32M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2.79M | 188.0K | -519.0K | -1.11M | 1.51M | 2.10M | 2.23M | 2.90M | 4.14M | 322.0K |
| Capital spending | -1.47M | -1.64M | -5.02M | -3.55M | -3.65M | -2.16M | -2.79M | -1.76M | -1.74M | -1.01M |
| Free cash flow | -4.26M | -1.45M | -5.54M | -4.66M | -2.15M | -63.0K | -562.0K | 1.13M | 2.40M | -686.0K |
| Cash from investing | -1.47M | -1.64M | -5.02M | -4.18M | -7.13M | -2.16M | -2.79M | -1.78M | -2.19M | -868.0K |
| Cash from financing | 3.58M | 1.93M | 6.86M | -500.0K | 92.0K | 2.55M | -296.0K | 11.3M | -1.80M | 1.17M |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | 18.0K | 14.7M | 0 | 6.00B | ||||||
| Change in cash | -683.0K | 477.0K | 1.32M | -5.79M | -5.53M | 2.48M | -858.0K | 12.4M | 141.0K | 625.0K |
Cap table
Built by 6ix from STRATA Skin Sciences, Inc.’s releases
- Common shares
- 5,888,199
- Fully diluted
- 5,888,199
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,888,199 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,888,199 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Gill Other companies: Telix Pharmaceuticals Limited (Chair & Independent Non-Executive Director · Since at least May 11, 2026); Y mAbs Therapeutics (Director · Since at least Sep 20, 2018); Evolus, Inc. Common Stock (Director · Since at least Feb 12, 2018); Strongbridge Biopharma plc (Director · Sep 3, 2019 – Oct 5, 2021 · Past); Melinta Therapeutics Inc (Director · May 25, 2018 – Jun 11, 2019 · Past); Ocugen, Inc. (Director · Dec 9, 2016 – Jun 15, 2018 · Past); Cempra Inc (Director · Jan 1, 2016 – Jan 3, 2017 · Past); EndoChoice Holdings Inc (President and CFO · Aug 14, 2015 – Nov 22, 2016 · Past) | Director · May 30, 2018 – Nov 22, 2019 · Past |
| Nachum Shamir Other companies: MediWound Ltd. (Chairman · Since at least Mar 18, 2026); Stereotaxis, Inc. (Director · Since at least Jul 18, 2024); IsoPlexis Corp (Director · Aug 22, 2022 – Mar 21, 2023 · Past); Cactus Acquisition Corp. 1 Limited (Director · Oct 28, 2021 – Oct 28, 2021 · Past); Cogentix Medical Inc (Director · Nov 3, 2016 – Apr 23, 2018 · Past) | Director · May 30, 2018 – Jul 5, 2023 · Past |
| Samuel E Navarro Other companies: Streamex Corp. (Director · Jun 21, 2019 – Dec 28, 2021 · Past); Derma Sciences Inc (Director · May 28, 2015 – Feb 24, 2017 · Past); Dextera Surgical Inc (Director · Dec 11, 2014 – Nov 22, 2016 · Past); MELA Sciences Inc (Director · Mar 11, 2014 – Dec 1, 2015 · Past) | Director · Dec 6, 2016 – Oct 9, 2020 · Past |
| LuAnn Via Other companies: MELA Sciences Inc (Director · Apr 26, 2012 – Dec 1, 2015 · Past); Collective Brands Inc (President and CEO - Payless · Mar 10, 2009 – Oct 9, 2012 · Past) | Director · Dec 6, 2016 – Jul 20, 2021 · Past |
| Uri Geiger Other companies: NeuroPace, Inc. (Director · Since at least Jan 5, 2023); Minerva Surgical, Inc. (Director · Feb 9, 2023 – Feb 9, 2023 · Past) | Director · Jul 15, 2024 – Jul 15, 2024 · Past |
| Samuel Rubinstein Other companies: MediWound Ltd. (Director · Since at least Mar 18, 2026) | Director · Since at least May 30, 2018 |
| Dolev Rafaeli | Chief Executive Officer, Director · Apr 10, 2018 – May 13, 2025 · Past |
| Erica Jordan | President and Chief Executive Officer · Since at least Nov 5, 2026 |
| Irit Yaniv | Director · Since at least Oct 26, 2023 |
Log in to ask 6ix AI your own questions about STRATA Skin Sciences, Inc.